Work

Fts3‐01‐02: Subgroup Populations in Amaranth, a Randomized Phase 2/3 Study in Early Alzheimer's Disease With Lanabecestat

Year: 2019

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2019.06.4619

Authors: Pierre N. Tariot, Katherine J. Selzler, Alette M. Wessels, Scott W. Andersen, Jamie Mullen, Jennifer A. Zimmer, John R. Sims

Institutions: Banner Alzheimer’s Institute, Eli Lilly (United States), AstraZeneca (United States)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2981138541

FWCI: 0.172

Cites:

Cited by: 1

Related to: 10